by Samuel Nee | Dec 7, 2023 | Company, Management Team
Ian Leitch has been Director of Clinical Research of Opthea since September 2011. He has over 20 years of research and management experience from drug discovery through clinical development in biotechnology/pharmaceutical companies. For the five years prior to joining...
by Samuel Nee | Nov 17, 2023 | Company, Management Team
Mike Gerometta has been Head of Chemistry, Manufacturing & Controls (CMC) Development for Opthea since 2008 with responsibilities encompassing outsourcing of Opthea’s biopharmaceutical research and cGMP manufacturing activities for its therapeutic and diagnostic...
by Samuel Nee | Oct 16, 2023 | Company, Management Team
Mark O’Neill was appointed Vice President CMC in January 2022. Mr. O’Neill was most recently head of Process Development for Avexis Gene therapies where he orchestrated all product development and technical operations activities pertaining to the startup and...
by Samuel Nee | Sep 15, 2023 | Company, Management Team
Karen Adams was appointed Vice President Finance in May 2021 and Company Secretary in June 2021. Karen is accountable directly to the board, through the chair, on all matters to do with the proper functioning of Opthea’s board. Prior to joining Opthea, Karen was the...
by Samuel Nee | Aug 16, 2023 | Company, Management Team
Bruno joined Opthea in July 2022 and leads Global Clinical Operations. Bruno is former Sr. Vice President of Development Operations at Eidos Therapeutics, a BridgeBio company in San Francisco, CA. He also served as Vice President of Clinical Operations at BioMarin...
